FORT MYERS, FLA. – Jorge Polanco's strong second half of last season was one reason why the Twins made the playoffs for the first time since 2010.
A return to the playoffs will have to be done without him — for about half of the upcoming season. And forget about him participating if the Twins do play in October.
Polanco, 24, was suspended 80 games for violating Major League Baseball's drug policy. He tested positive for the drug stanozolol, a performance-enhancing substance. If that sounds familiar, there's a good reason why. Righthander Ervin Santana served the same suspension for testing positive for the same substance in 2015, only a few months after he signed with the Twins as their most expensive free agent ever.
Polanco will experience the same fate. He won't be eligible to play until June 30 against the Cubs in Chicago. And he is ineligible for postseason play.
Polanco was not available for comment Sunday — he will meet with reporters Monday — but released a statement through the Major League Baseball Players Association.
"Today, I have regretfully accepted my 80-game suspension for testing positive for stanozolol," Polanco said. "To be clear, I did not intentionally consume this steroid. I now know, however, that my intention alone is not a good enough excuse and I will pay the price for my error in judgment."
Stanozolol became well-known during the 1988 Seoul Olympics, when Canadian sprinter Ben Johnson tested positive for it and was stripped of his medals. Santana's positive test occurred during a period in which a handful of players were caught using stanozolol, one of 74 performance-enhancing drugs on MLB's list of banned substances. At least two minor leaguers have tested positive for the substance since the beginning of 2018.
In his statement, Polanco argued that he was unaware of how the substance got into his system, similar to Santana's defense.